The MarketWatch News Department was not involved in the creation of this content.
Dec 22, 2020 (Heraldkeepers) —
The infectious disease drugs market is segmented on the lines of its disease, treatment, end-use and regional. The basis of disease the market is segmented into Bacterial Disease, Viral Disease, Fungal Disease, and Parasitic Disease. Based on treatment the global infectious disease drugs market covers Antibacterial, Antifungal, Antiviral, Anti parasitic, and Alternative Medicine. On the basis of distribution channel, the market is segregated into Pharmacies, Grocery Stores, Vitamin & Health Food Stores, and Online Pharmacies. The infectious disease drugs market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
The scope of the report includes a detailed study of infectious disease drugs market with the reasons given for variations in the growth of the industry in certain regions.
Browse Full Report: https://www.marketresearchengine.com/infectious-disease-drugs-market
The infectious disease drugs market size is mainly driven by rising prevalence of the infectious diseases across the globe. Extensive research activities being carried out by the major industry players is driving the business growth rate during the foreseeable period. Furthermore, launch of novel drugs in the marketplace such as direct acting antivirals will further support in improving industry revenue generation till 2024.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include F. Hoffmann-La Roche, AstraZeneca, Bayer AG, GlaxoSmithKline, Pfizer, Gilead Sciences, Bristol-Myers Squibb Company, Sanofi, Merck, Johnson & Johnson, Novartis, AbbVie and Auritec Pharmaceuticals. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.
In addition, the developing countries such as India and China, government initiatives and several programs are launched to promote awareness related to infectious diseases nationally. These initiatives will supplement the market growth over the study period. Increasing number of product launches and rise in merger and acquisitions among the industry players are the emerging trends of the global infectious disease drugs business. However, expiry of the patent products followed by rising preference for generic drugs may slowdown the business improvement between 2018 and 2024.
- Hoffmann-La Roche, AstraZeneca, Bayer AG, GlaxoSmithKline, Pfizer, Gilead Sciences, Bristol-Myers Squibb Company, Sanofi, Merck, Johnson & Johnson, Novartis, AbbVie and Auritec Pharmaceuticals are among the major players in the global infectious disease drugs market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Infectious Disease Drugs Market has been segmented as below:
The Infectious Disease Drugs Market is segmented on the lines of Infectious Disease Drugs Market, By Disease, Infectious Disease Drugs Market, By Treatment, Infectious Disease Drugs Market, By Distribution Channel and Infectious Disease Drugs Market, By Region.
Infectious Disease Drugs Market, By Disease this market is segmented on the basis of Bacterial Disease, Viral Disease, Fungal Disease and Parasitic Disease. Infectious Disease Drugs Market, By Treatment this market is segmented on the basis of Antibacterial, Antifungal, Antiviral, Antiparasitic and Alternative Medicine. Infectious Disease Drugs Market, By Distribution Channel this market is segmented on the basis of Pharmacies, Grocery Stores, Vitamin & Health Food Stores, Online Pharmacies and Others. Infectious Disease Drugs Market, By Region this market is segmented on the basis of North America, Europe, Asia Pacific and Rest of World.
The report covers:
- An overview of the global infectious disease drugs market and related technologies
- Analyses of global market trends, with actual data for 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2024
- Identifications of new market opportunities and targeted promotional plans for infectious disease drugs market
- Discussion of research and development, and the demand for new products and new applications.
- Comprehensive company profiles of major players in the industry.
Reasons to Buy this Report:
- Obtain the most up to date information available on the infectious disease drugs market
- Identify growth segments and opportunities in the industry
- Facilitate decision making on the basis of strong historic and forecast for infectious disease drugs market
- Assess your competitor’s refining portfolio and its evolution
Request Sample Report from here: https://www.marketresearchengine.com/infectious-disease-drugs-market
Table of Contents:
- Research Methodology
- Executive Summary
4.1. Introduction 4.2. Drivers 4.2.1. Rising prevalence of infectious diseases 4.2.2. Patent expiration of branded drugs 4.2.3. Driver 3 4.3. Restraints 4.3.1. Lack of reimbursement in developing countries 4.4. Opportunities 4.4.1. Increasing funding activities by various organizations 4.4.2. Upsurge in awareness activities by non-profit organization 4.5. Challenges 4.5.1. Less penetration of diagnosis and treatment
- Infectious Disease Drugs Market, By Disease
- Infectious Disease Drugs Market, By Treatment
- Infectious Disease Drugs Market, By Distribution Channel
- Competitive Landscape
9.1. F. Hoffmann-La Roche 9.1.1. Company Overview 9.1.2. Product/Service Landscape 9.1.3. Financial Overview 9.1.4. Recent Developments 9.2. AstraZeneca 9.2.1. Company Overview 9.2.2. Product/Service Landscape 9.2.3. Financial Overview 9.2.4. Recent Developments 9.3. Bayer AG 9.3.1. Company Overview 9.3.2. Product/Service Landscape 9.3.3. Financial Overview 9.3.4. Recent Developments 9.4. GlaxoSmithKline 9.4.1. Company Overview 9.4.2. Product/Service Landscape 9.4.3. Financial Overview 9.4.4. Recent Developments 9.5. Pfizer 9.5.1. Company Overview 9.5.2. Product/Service Landscape 9.5.3. Financial Overview 9.5.4. Recent Developments 9.6. Gilead Sciences 9.6.1. Company Overview 9.6.2. Product/Service Landscape 9.6.3. Financial Overview 9.6.4. Recent Developments 9.7. Bristol-Myers Squibb Company 9.7.1. Company Overview 9.7.2. Product/Service Landscape 9.7.3. Financial Overview 9.7.4. Recent Developments 9.8. Sanofi 9.8.1. Company Overview 9.8.2. Product/Service Landscape 9.8.3. Financial Overview 9.8.4. Recent Developments 9.9. Merck 9.9.1. Company Overview 9.9.2. Product/Service Landscape 9.9.3. Financial Overview 9.9.4. Recent Developments 9.10. Johnson & Johnson 9.10.1. Company Overview 9.10.2. Product/Service Landscape 9.10.3. Financial Overview 9.10.4. Recent Developments 9.11. Novartis 9.11.1. Company Overview 9.11.2. Product/Service Landscape 9.11.3. Financial Overview 9.11.4. Recent Developments 9.12. AbbVie 9.12.1. Company Overview 9.12.2. Product/Service Landscape 9.12.3. Financial Overview 9.12.4. Recent Developments 9.13. Auritec Pharmaceuticals 9.13.1. Company Overview 9.13.2. Product/Service Landscape 9.13.3. Financial Overview 9.13.4. Recent Developments
Other Related Market Research Reports:
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Email: [email protected]
Country: United States
The MarketWatch News Department was not involved in the creation of this content.